New insight of functional molecular imaging into the atheroma biology: 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results

Clinical Physiology and Functional Imaging

Volumn 36, Issue 6, 2016, Pages 499-503

  Quirce, R ^a   Martinez Rodriguez I ^a   Banzo, I ^a   Jimenez Bonilla J ^a   Martinez Amador N ^a   Ibanez Bravo S ^a   Lopez Defillo J ^a   Jimenez Alonso M ^a   Revilla, M A ^a   Carril, J M ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

18F FDG; 18F sodium fluoride; atherosclerosis; calcification; carotid; inflammation; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; SODIUM FLUORIDE F 18; RADIOPHARMACEUTICAL AGENT; SODIUM FLUORIDE;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; ATHEROMA; CALCIFICATION; CAROTID ATHEROMA; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; IMAGING AND DISPLAY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TARGET BACKGROUND RATIO; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; CAROTID ARTERY; CAROTID ARTERY DISEASE; COMPARATIVE STUDY; COMPLICATION; DIAGNOSTIC IMAGING; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PREDICTIVE VALUE; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; CAROTID ARTERIES; CAROTID ARTERY DISEASES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SODIUM FLUORIDE; STROKE; VASCULAR CALCIFICATION;

EID: 84936797937     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/cpf.12254     Document Type: Article

References (22)

1. Aikawa E, Nahrendorf M, Figueiredo JL, et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation (2007); 116: 2841–2850.
2. Brott TG, Halperin JL, Abbara S, et al. ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the management of patients with extracranial carotid and vertebral artery disease. J Am Coll Cardiol (2011); 57: 1002–1044.
3. Chen W, Dilsizian V. Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose. Curr Cardiol Rep (2013); 15: 364–369.
4. Cho HJ, Cho HJ, Lee HJ, et al. Vascular calcifying progenitor cells possess bidirectional differentiation potentials. PLoS Biol (2013); 11: e1001534. doi:10.1371/journal.pbio.1001534.
5. Cocker MS, Mc Ardle B, Spence JD, et al. Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see. J Nucl Cardiol (2012); 19: 1211–1225.
6. Derlin T, Richter U, Bannas P, et al. Feasibility of 18F-Sodium Fluoride PET/CT for imaging of atherosclerotic plaque. J Nucl Med (2010); 51: 862–865.
7. Dweck MR, Jones C, Joshi NV, et al. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation (2012a); 125: 76–86.
8. Dweck MR, Chow MW, Joshi NV, et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol (2012b); 59: 1539–1548.
9. Joshi NV, Vesey AT, Williams MC, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet (2014); 383: 705–713.
10. Lederman RJ, Raylman RR, Fisher SJ, et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun (2001); 22: 747–753.
11. Lee SJ, On YK, Lee EJ, et al. Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction. J Nucl Med (2008); 49: 1277–1282.
12. Maldonado N, Kelly-Arnold A, Vengrenyuk Y, et al. A mechanistic analysis of the role of microcalcifications in atherosclerotic plaque stability: potential implications for plaque rupture. Am J Physiol Heart Circ Physiol (2012); 303: H619–H628.
13. New SE, Aikawa E. Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circ Res (2011); 108: 1381–1391.
14. Pedersen SF, Hag AM, Klausen TL, et al. Positron emission tomography of the vulnerable atherosclerotic plaque in man – a contemporary review. Clin Physiol Funct Imaging (2014); 34: 413–425.
15. Quirce R, Banzo I, Martínez-Rodríguez I, et al. New insight of molecular imaging into the atheroma biology: (18)F-fluoride PET/CT and 18F-FDG PET/CT of 3 carotid plaques in a symptomatic neurologic patient. Clin Nucl Med (2013a); 38: 451–452.
16. Quirce R, Martínez-Rodríguez I, De Arcocha Torres M, et al. Contribution of 18F-sodium fluoride PET/CT to the study of the carotid atheroma calcification. Rev Esp Med Nucl Imagen Mol (2013b); 32: 22–25.
17. Rominger A, Saam T, Wolpers S, et al. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med (2009); 50: 1611–1620.
18. Rudd JHF, Warburton EA, Fryer TD, et al. Imaging atherosclerotic plaque inflammation with 18F-fluorodeoxyglucose positron emission tomography. Circulation (2002); 105: 2708–2711.
19. Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol (2006); 48: 1818–1824.
20. Vallabhajosula S, Machac J, Knesaurek K. Imaging atherosclerotic macrophage density by positron emission tomography using F-18 fluorodeoxyglucose (FDG). J Nucl Med (1996); 37: 38.
21. Vengrenyuk Y, Carlier S, Xanthos S, et al. A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps. Proc Natl Acad Sci USA (2006); 103: 14678–14683.
22. Wu YW, Kao HL, Huang CL, et al. The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers. Eur J Nucl Med Mol Imaging (2012); 39: 399–407.